Ovarian reserve testing provides a window into the quantity and, indirectly, the quality of your remaining egg supply. For ICI candidates, these tests do not predict with certainty whether you will conceive — but they profoundly inform how urgently to proceed, which protocols to use, and when to escalate. Understanding what each test measures and how to interpret the numbers empowers better decisions at every stage of the ICI journey.
AMH: The Most Informative Single Reserve Test
Anti-Mullerian hormone (AMH) is produced by granulosa cells of small antral follicles and provides the most stable, cycle-independent measure of ovarian reserve available. Unlike FSH and estradiol, which fluctuate significantly with the menstrual cycle, AMH levels remain relatively constant regardless of cycle day — a key practical advantage that allows testing on any day of the cycle. Reference ranges vary slightly by laboratory, but broadly: AMH above 2.0 ng/mL indicates normal to high reserve; 1.0–2.0 ng/mL indicates low-normal reserve; 0.5–1.0 ng/mL indicates diminished reserve; below 0.5 ng/mL indicates severely diminished reserve.
Important limitations of AMH: it predicts ovarian response to stimulation (how many eggs can be retrieved in an IVF cycle) but does not directly predict egg quality or per-cycle natural pregnancy rates as reliably as it predicts IVF response. A woman with low AMH but normal age may still have good-quality eggs — reserve is distinct from quality. AMH also does not predict the onset of menopause with precision; low AMH reflects a small remaining follicle pool but does not indicate imminent menopause on a clinically relevant timeline for most reproductive-age women. The clinical utility of AMH for ICI candidates is primarily in identifying very low reserve that should prompt expedited evaluation and protocol acceleration, not as a binary predictor of ability to conceive.
Day-3 FSH and Estradiol
Follicle-stimulating hormone (FSH) measured on cycle day 2–4 reflects the pituitary’s assessment of ovarian responsiveness. As the ovarian follicle pool declines with age or disease, the pituitary increases FSH output to attempt to recruit a follicle — thus elevated day-3 FSH signals reduced ovarian reserve. Normal day-3 FSH is below 10 mIU/mL in most laboratory reference ranges; values of 10–15 mIU/mL indicate diminished reserve; above 15–20 mIU/mL indicates significantly reduced reserve; above 25 mIU/mL may indicate premature ovarian insufficiency. Day-3 estradiol must be measured simultaneously with FSH because elevated early follicular phase estradiol (above 70 pg/mL) suppresses FSH, potentially making FSH appear falsely normal in a cycle where reserve is actually declining.
Day-3 FSH has significant cycle-to-cycle variability — a value may be normal in one cycle and elevated in the next. The clinically operative principle is that the highest value observed is the most biologically meaningful: a single elevated FSH, even flanked by normal values in adjacent cycles, is clinically significant. This variability means that serial testing provides more information than a single data point, but the presence of even one abnormal value deserves investigation rather than reassurance based on subsequent normal values. For ICI candidates, day-3 FSH and estradiol are typically part of a baseline fertility panel ordered alongside AMH, and together they provide complementary information that neither alone supplies.
Antral Follicle Count (AFC)
The antral follicle count (AFC) is a transvaginal ultrasound measurement of small antral follicles (2–10 mm diameter) visible in both ovaries on cycle days 2–5. AFC provides a direct anatomical correlate to the remaining primordial follicle pool — each visible antral follicle represents a cohort of follicles recently recruited from the primordial pool. AFC is the strongest single predictor of ovarian response to stimulation in IVF and provides information complementary to AMH for ICI candidates who want the most complete reserve picture.
Normal AFC ranges are 10–30 total follicles; AFC below 7 is consistently associated with diminished reserve and reduced response to ovulation induction; AFC above 30 suggests PCOS pattern or risk of hyperstimulation. AFC is operator-dependent — the skill and equipment of the sonographer and the quality of the ultrasound machine affect count accuracy. For ICI candidates performing AFC through a general OB-GYN office versus a reproductive endocrinology center, there may be differences in counting protocol and equipment sensitivity. A count performed at a fertility-specialized ultrasound center is more standardized and reliable. If AFC from a general OB-GYN seems inconsistent with your AMH result, repeat testing at a fertility specialist is worthwhile.
Interpreting Combined Reserve Results
The most useful approach to reserve interpretation is to consider all test results together rather than any single value in isolation. A woman with AMH 1.2 ng/mL (low-normal), day-3 FSH 9 mIU/mL (borderline), and AFC 8 (slightly low) has a consistent picture of modestly diminished reserve that warrants expedited ICI protocol without panic — she is not facing imminent infertility, but she has less biological runway than average and should proceed deliberately rather than deferring for months. A woman with discordant results — normal AMH but elevated FSH — benefits from RE consultation to interpret the discordance, which may reflect a single fluctuating cycle value or may indicate a specific pathology.
For ICI protocol implications, the combined reserve results should inform: the appropriate trial horizon before escalating to clinical evaluation (shorter for diminished reserve), the urgency of beginning and the wisdom of deferring cycles for non-clinical reasons (reconsidered in the context of diminished reserve), and whether ovulation induction monitoring should be part of the protocol from the start (more strongly indicated with diminished reserve, where natural cycle quality may be more variable). Reserve results do not determine whether ICI can work — they calibrate the timeline and intensity of the protocol to match the urgency imposed by your individual biology.
For a complete at-home insemination solution, the MakeAmom Babymaker Kit includes everything you need for a properly timed, sterile ICI cycle. For a complete at-home insemination solution, the His Fertility Boost includes everything you need for a properly timed, sterile ICI cycle.
Further reading across our network: IntracervicalInsemination.org · MakeAmom.com · IntracervicalInseminationKit.info
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making decisions about your fertility care.
